The steep rise in CMPs for violations of the complex regulatory landscape in which the pharma
\nindustry operates has led to the need for robust compliance programs. If anything, reporting entities need to get their data right.<\/p>\n

What this means is that their data needs to be complete, accurate, and even supported by appropriate documentation.<\/p>\n

What\u2019s most important is that they understand what their data is saying about them and their practices pertaining to interactions with physicians and teaching hospitals \u2013 and this is where Open Payments Analytics comes in.<\/p>\n

There are many different aspects of their data that pharma manufacturers should be aware of:<\/p>\n

What is the breakdown of payments by payment type and dollar volume?<\/p>\n

Who are the highest-paid physicians?<\/p>\n

Are physicians receiving both promotional payments (such as speaker or consulting fees) and research payments?<\/p>\n

Dedicated to helping pharma companies inspect their spend for accuracy and completeness, Open Payments Analytics assists in understanding what is in the data, including how budgets are being spent from a promotional, research, and investment standpoint. All of these elements are critical to ensuring that appropriate resources are being allocated by the company to address risks and conflicts.<\/p>\n